Literature DB >> 9457121

Tocolytic magnesium sulphate and paediatric mortality.

C Crowther, J Hiller, L Doyle, J Lumley, J Carlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9457121     DOI： 10.1016/S0140-6736(05)78241-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

2.  Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.

Authors:  Caroline A Crowther; Philippa F Middleton; Dominic Wilkinson; Pat Ashwood; Ross Haslam
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-09       Impact factor: 3.007

3.  The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761].

Authors: 
Journal:  BMC Pregnancy Childbirth       Date:  2004-03-08       Impact factor: 3.007

Review 4.  Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application.

Authors:  Clément Chollat; Loïc Sentilhes; Stéphane Marret
Journal:  Front Neurol       Date:  2018-04-16       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.